severe acute respiratory syndrome, SARS, Polymerase Chain Reaction, molecular testing, United States
In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspect SARS and 9 (47%) of 19 patients with probable SARS.
Janice K. Louie, Jill K. Hacker, Jennifer Mark, Shilpa S. Gavali, Shigeo Yagi, Alex Espinosa, David P. Schnurr, Cynthia K. Cossen, Erin R. Isaacson, Carol A. Glaser, Marc Fischer, Arthur L Reingold, Duc J. Vugia
Centers for Disease Control and Prevention
Infectious and parasitic diseases, Medicine